Rare diseases
Investigational molecules
Locations
A study to evaluate the safety and how the body uses ublituximab injections in patients with multiple sclerosis
PolandStudy on the Effectiveness of Ublituximab and Drug Combination for Patients with Relapsing Multiple Sclerosis
PolandStudy of ublituximab compared to fingolimod for children and teenagers aged 10 to 17 years with relapsing multiple sclerosis
PolandStudy of KYV-101 Therapy for Patients with Refractory Primary and Secondary Progressive Multiple Sclerosis
AustriaStudy on Ublituximab for Patients with Relapsing Multiple Sclerosis
CroatiaStudy comparing subcutaneous versus intravenous ublituximab in patients with relapsing multiple sclerosis
BulgariaStudy on the Effectiveness of Autologous Stem Cell Transplantation with Cytarabine in Patients with Aggressive Multiple Sclerosis
ItalyStudy on Ublituximab and Drug Combination for Patients with Myasthenia Gravis or Relapsing Multiple Sclerosis
PolandTell us about your condition – we search every trial in Europe and connect you with the right site.
